Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)

Recruiting N/A Interventional Study
Preterm Labor
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
3,600 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to clinically validate the predictive performance (sensitivity and specificity) of the PrediMAP in-vitro diagnostic medical device to predict delivery within 7 days in the target population of women consulting obstetric emergencies for preterm labor (PTL).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Pregnant with live fetus(es) * Emergency room visit between 22 and 34 days of pregnancy + 6 days * For a suspicion of PTL defined by : * Uterine contractions (UC) objectified during the consultation (questioning, clinical examination, external tocography), * And/or clinic…
Contacts

Jeanne SIBIUDE, MD, PhD

+33 1 47 60 66 11

jeanne.sibiude@aphp.fr

CONTACT

Karima MESBAHI IHADJADENE, Project Manager

33 1 58 41 12 11

karima.mesbahi@aphp.fr

CONTACT